{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:36:01Z","timestamp":1785036961614,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","award":["IFH18-24"],"award-info":[{"award-number":["IFH18-24"]}],"id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02720-y","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:52:51Z","timestamp":1744224771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development of an RT-RPA assay for La Crosse virus detection provides insights into age-dependent neuroinvasion in mice"],"prefix":"10.1186","volume":"22","author":[{"given":"Lily","family":"Lumkong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Alatrash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainetra","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince Baffour","family":"Tonto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby Brooke","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"2720_CR1","doi-asserted-by":"crossref","unstructured":"Alatrash R, Herrera BB. The adaptive immune response against bunyavirales. Viruses. 2024;16(3).","DOI":"10.3390\/v16030483"},{"key":"2720_CR2","doi-asserted-by":"crossref","unstructured":"Evans AB, Peterson KE. Throw out the map: neuropathogenesis of the globally expanding California serogroup of orthobunyaviruses. Viruses. 2019;11(9).","DOI":"10.3390\/v11090794"},{"issue":"1","key":"2720_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1128\/JVI.79.1.234-244.2005","volume":"79","author":"SS Soldan","year":"2005","unstructured":"Soldan SS, Plassmeyer ML, Matukonis MK, Gonzalez-Scarano F. La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. J Virol. 2005;79(1):234\u201344.","journal-title":"J Virol"},{"issue":"10","key":"2720_CR4","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1128\/JVI.01933-06","volume":"81","author":"G Blakqori","year":"2007","unstructured":"Blakqori G, Delhaye S, Habjan M, Blair CD, Sanchez-Vargas I, Olson KE, et al. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol. 2007;81(10):4991\u20139.","journal-title":"J Virol"},{"issue":"2","key":"2720_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.virol.2010.04.012","volume":"404","author":"SS Soldan","year":"2010","unstructured":"Soldan SS, Hollidge BS, Wagner V, Weber F, Gonzalez-Scarano F. La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic. Virology. 2010;404(2):139\u201347.","journal-title":"Virology"},{"key":"2720_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1743-422X-5-164","volume":"5","author":"SM Reese","year":"2008","unstructured":"Reese SM, Blitvich BJ, Blair CD, Geske D, Beaty BJ. Black WCt. Potential for La Crosse virus segment reassortment in nature. Virol J. 2008;5:164.","journal-title":"Virol J"},{"key":"2720_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1743-422X-4-41","volume":"4","author":"RS Bennett","year":"2007","unstructured":"Bennett RS, Ton DR, Hanson CT, Murphy BR, Whitehead SS. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes. Virol J. 2007;4:41.","journal-title":"Virol J"},{"issue":"1","key":"2720_CR8","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41467-022-28428-z","volume":"13","author":"B Arragain","year":"2022","unstructured":"Arragain B, Durieux Trouilleton Q, Baudin F, Provaznik J, Azevedo N, Cusack S, et al. Structural snapshots of La Crosse virus polymerase reveal the mechanisms underlying Peribunyaviridae replication and transcription. Nat Commun. 2022;13(1):902.","journal-title":"Nat Commun"},{"issue":"1","key":"2720_CR9","doi-asserted-by":"publisher","first-page":"e0011065","DOI":"10.1371\/journal.pntd.0011065","volume":"17","author":"CA Day","year":"2023","unstructured":"Day CA, Odoi A, Trout Fryxell R. Geographically persistent clusters of La Crosse virus disease in the Appalachian region of the united States from 2003 to 2021. PLoS Negl Trop Dis. 2023;17(1):e0011065.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2720_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0891-5520(05)70410-4","volume":"12","author":"JE McJunkin","year":"1998","unstructured":"McJunkin JE, Khan RR, Tsai TF. California-La Crosse encephalitis. Infect Dis Clin North Am. 1998;12(1):83\u201393.","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"2720_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4269\/ajtmh.23-0160","volume":"110","author":"T Goldman","year":"2024","unstructured":"Goldman T, Hamer DH. Current status of La Crosse virus in North America and potential for future spread. Am J Trop Med Hyg. 2024;110(5):850\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"2720_CR12","doi-asserted-by":"publisher","first-page":"e6145","DOI":"10.1371\/journal.pone.0006145","volume":"4","author":"AD Haddow","year":"2009","unstructured":"Haddow AD, Odoi A. The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the Eastern united States, 2003\u20132007. PLoS ONE. 2009;4(7):e6145.","journal-title":"PLoS ONE"},{"key":"2720_CR13","unstructured":"CDC. La Cross virus [Available from: https:\/\/www.cdc.gov\/la-crosse-encephalitis\/about\/index.html]"},{"issue":"3","key":"2720_CR14","doi-asserted-by":"publisher","first-page":"e642","DOI":"10.1542\/peds.2014-0498","volume":"134","author":"JT Gaensbauer","year":"2014","unstructured":"Gaensbauer JT, Lindsey NP, Messacar K, Staples JE, Fischer M. Neuroinvasive arboviral disease in the united States: 2003 to 2012. Pediatrics. 2014;134(3):e642\u201350.","journal-title":"Pediatrics"},{"issue":"4","key":"2720_CR15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3201\/eid2504.181016","volume":"25","author":"AB Evans","year":"2019","unstructured":"Evans AB, Winkler CW, Peterson KE. Differences in neuropathogenesis of encephalitic California serogroup viruses. Emerg Infect Dis. 2019;25(4):728\u201338.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2720_CR16","doi-asserted-by":"publisher","first-page":"ofx150","DOI":"10.1093\/ofid\/ofx150","volume":"4","author":"L Lau","year":"2017","unstructured":"Lau L, Wudel B, Kadkhoda K, Keynan Y. Snowshoe hare virus causing meningoencephalitis in a young adult from Northern Manitoba, Canada. Open Forum Infect Dis. 2017;4(3):ofx150.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"2720_CR17","doi-asserted-by":"publisher","first-page":"e1114","DOI":"10.1093\/cid\/ciac403","volume":"76","author":"AE Boutzoukas","year":"2023","unstructured":"Boutzoukas AE, Freedman DA, Koterba C, Hunt GW, Mack K, Cass J, et al. La Crosse virus neuroinvasive disease in children: A contemporary analysis of clinical\/neurobehavioral outcomes and predictors of disease severity. Clin Infect Dis. 2023;76(3):e1114\u201322.","journal-title":"Clin Infect Dis"},{"key":"2720_CR18","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1017\/S0950268818003096","volume":"147","author":"S Harding","year":"2018","unstructured":"Harding S, Greig J, Mascarenhas M, Young I, Waddell LA. La Crosse virus: a scoping review of the global evidence. Epidemiol Infect. 2018;147:e66.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"2720_CR19","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/jme\/tjad090","volume":"60","author":"CA Day","year":"2023","unstructured":"Day CA, Byrd BD, Trout Fryxell RT. La Crosse virus neuroinvasive disease: the kids are not alright. J Med Entomol. 2023;60(6):1165\u201382.","journal-title":"J Med Entomol"},{"issue":"1","key":"2720_CR20","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1038\/s41467-023-37833-x","volume":"14","author":"R Basu","year":"2023","unstructured":"Basu R, Ganesan S, Winkler CW, Anzick SL, Martens C, Peterson KE, et al. Identification of age-specific gene regulators of La Crosse virus neuroinvasion and pathogenesis. Nat Commun. 2023;14(1):2836.","journal-title":"Nat Commun"},{"issue":"12","key":"2720_CR21","doi-asserted-by":"publisher","first-page":"e0176224","DOI":"10.1128\/jvi.01762-24","volume":"98","author":"R Alatrash","year":"2024","unstructured":"Alatrash R, Vaidya V, Herrera BB. Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice. J Virol. 2024;98(12):e0176224.","journal-title":"J Virol"},{"issue":"1","key":"2720_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12974-021-02173-4","volume":"18","author":"R Basu","year":"2021","unstructured":"Basu R, Nair V, Winkler CW, Woods TA, Fraser IDC, Peterson KE. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death. J Neuroinflammation. 2021;18(1):125.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"2720_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.amjmed.2016.03.021","volume":"129","author":"AL Teleron","year":"2016","unstructured":"Teleron AL, Rose BK, Williams DM, Kemper SE, McJunkin JE. La Crosse encephalitis: an adult case series. Am J Med. 2016;129(8):881\u20134.","journal-title":"Am J Med"},{"issue":"9","key":"2720_CR24","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1128\/jcm.32.9.2076-2080.1994","volume":"32","author":"LP Wasieloski Jr","year":"1994","unstructured":"Wasieloski LP Jr., Rayms-Keller A, Curtis LA, Blair CD, Beaty BJ. Reverse transcription-PCR detection of LaCrosse virus in mosquitoes and comparison with enzyme immunoassay and virus isolation. J Clin Microbiol. 1994;32(9):2076\u201380.","journal-title":"J Clin Microbiol"},{"issue":"2\u20133","key":"2720_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.mam.2005.12.001","volume":"27","author":"F Watzinger","year":"2006","unstructured":"Watzinger F, Ebner K, Lion T. Detection and monitoring of virus infections by real-time PCR. Mol Aspects Med. 2006;27(2\u20133):254\u201398.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"2720_CR26","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1128\/JCM.43.4.1885-1889.2005","volume":"43","author":"AJ Lambert","year":"2005","unstructured":"Lambert AJ, Nasci RS, Cropp BC, Martin DA, Rose BC, Russell BJ, et al. Nucleic acid amplification assays for detection of La Crosse virus RNA. J Clin Microbiol. 2005;43(4):1885\u20139.","journal-title":"J Clin Microbiol"},{"key":"2720_CR27","doi-asserted-by":"crossref","unstructured":"Salcedo N, Sena BF, Qu X, Herrera BB. Comparative evaluation of rapid isothermal amplification and antigen assays for screening testing of SARS-CoV-2. Viruses. 2022;14(3).","DOI":"10.3390\/v14030468"},{"issue":"1","key":"2720_CR28","doi-asserted-by":"publisher","first-page":"16424","DOI":"10.1038\/s41598-021-95757-2","volume":"11","author":"AB Evans","year":"2021","unstructured":"Evans AB, Peterson KE. Cross reactivity of neutralizing antibodies to the encephalitic California serogroup orthobunyaviruses varies by virus and genetic relatedness. Sci Rep. 2021;11(1):16424.","journal-title":"Sci Rep"},{"issue":"7","key":"2720_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1373\/clinchem.2015.245829","volume":"62","author":"RK Daher","year":"2016","unstructured":"Daher RK, Stewart G, Boissinot M, Bergeron MG. Recombinase polymerase amplification for diagnostic applications. Clin Chem. 2016;62(7):947\u201358.","journal-title":"Clin Chem"},{"issue":"1","key":"2720_CR30","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1038\/s41598-021-82479-8","volume":"11","author":"M Faye","year":"2021","unstructured":"Faye M, Abd El Wahed A, Faye O, Kissenkotter J, Hoffmann B, Sall AA, et al. A recombinase polymerase amplification assay for rapid detection of rabies virus. Sci Rep. 2021;11(1):3131.","journal-title":"Sci Rep"},{"issue":"8","key":"2720_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1099\/jgv.0.001083","volume":"99","author":"NI Vasileva Wand","year":"2018","unstructured":"Vasileva Wand NI, Bonney LC, Watson RJ, Graham V, Hewson R. Point-of-care diagnostic assay for the detection of Zika virus using the recombinase polymerase amplification method. J Gen Virol. 2018;99(8):1012\u201326.","journal-title":"J Gen Virol"},{"key":"2720_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trac.2017.10.015","volume":"98","author":"IM Lobato","year":"2018","unstructured":"Lobato IM, O\u2019Sullivan CK. Recombinase polymerase amplification: basics, applications and recent advances. Trends Analyt Chem. 2018;98:19\u201335.","journal-title":"Trends Analyt Chem"},{"key":"2720_CR33","doi-asserted-by":"crossref","unstructured":"Sainetra Sridhar PBT, Lily Lumkong EM, Netto C, Brites, Wei-Kung, Wang. & Bobby Brooke Herrera. RT-RPA as a dual tool for detection and phylogenetic analysis of epidemic arthritogenic alphaviruses. Sci Rep. 2024;14.","DOI":"10.1038\/s41598-024-81763-7"},{"key":"2720_CR34","doi-asserted-by":"publisher","first-page":"37732","DOI":"10.1038\/srep37732","volume":"6","author":"M Jauset-Rubio","year":"2016","unstructured":"Jauset-Rubio M, Svobodova M, Mairal T, McNeil C, Keegan N, Saeed A, et al. Ultrasensitive, rapid and inexpensive detection of DNA using paper based lateral flow assay. Sci Rep. 2016;6:37732.","journal-title":"Sci Rep"},{"key":"2720_CR35","doi-asserted-by":"publisher","first-page":"114227","DOI":"10.1016\/j.jviromet.2021.114227","volume":"296","author":"TR Shelite","year":"2021","unstructured":"Shelite TR, Uscanga-Palomeque AC, Castellanos-Gonzalez A, Melby PC, Travi BL. Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19. J Virol Methods. 2021;296:114227.","journal-title":"J Virol Methods"},{"issue":"1","key":"2720_CR36","doi-asserted-by":"publisher","first-page":"20593","DOI":"10.1038\/s41598-020-77692-w","volume":"10","author":"DK Ghosh","year":"2020","unstructured":"Ghosh DK, Kokane SB, Gowda S. Development of a reverse transcription recombinase polymerase based isothermal amplification coupled with lateral flow immunochromatographic assay (CTV-RT-RPA-LFICA) for rapid detection of citrus Tristeza virus. Sci Rep. 2020;10(1):20593.","journal-title":"Sci Rep"},{"issue":"4","key":"2720_CR37","first-page":"289","volume":"85","author":"J Davis","year":"2024","unstructured":"Davis J, Atkins C, Doyle M, Williams C, Boyce R, Byrd B. Endemic La Crosse virus neuroinvasive disease in North Carolina residents: 2000\u20132020. N C Med J. 2024;85(4):289\u201395.","journal-title":"N C Med J"},{"issue":"19","key":"2720_CR38","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1128\/JVI.01866-14","volume":"88","author":"KG Taylor","year":"2014","unstructured":"Taylor KG, Woods TA, Winkler CW, Carmody AB, Peterson KE. Age-dependent myeloid dendritic cell responses mediate resistance to La Crosse virus-induced neurological disease. J Virol. 2014;88(19):11070\u20139.","journal-title":"J Virol"},{"key":"2720_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1743-422X-5-25","volume":"5","author":"RS Bennett","year":"2008","unstructured":"Bennett RS, Cress CM, Ward JM, Firestone CY, Murphy BR, Whitehead SS. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys. Virol J. 2008;5:25.","journal-title":"Virol J"},{"issue":"3","key":"2720_CR40","doi-asserted-by":"publisher","first-page":"e1010384","DOI":"10.1371\/journal.ppat.1010384","volume":"18","author":"AB Evans","year":"2022","unstructured":"Evans AB, Winkler CW, Peterson KE. Differences in neuroinvasion and protective innate immune pathways between encephalitic California serogroup orthobunyaviruses. PLoS Pathog. 2022;18(3):e1010384.","journal-title":"PLoS Pathog"},{"issue":"1","key":"2720_CR41","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1038\/s41467-020-19258-y","volume":"11","author":"J Qian","year":"2020","unstructured":"Qian J, Boswell SA, Chidley C, Lu ZX, Pettit ME, Gaudio BL, et al. An enhanced isothermal amplification assay for viral detection. Nat Commun. 2020;11(1):5920.","journal-title":"Nat Commun"},{"issue":"8","key":"2720_CR42","doi-asserted-by":"publisher","first-page":"e2126931","DOI":"10.1001\/jamanetworkopen.2021.26931","volume":"4","author":"A Harmon","year":"2021","unstructured":"Harmon A, Chang C, Salcedo N, Sena B, Herrera BB, Bosch I, et al. Validation of an At-Home direct antigen rapid test for COVID-19. JAMA Netw Open. 2021;4(8):e2126931.","journal-title":"JAMA Netw Open"},{"key":"2720_CR43","doi-asserted-by":"publisher","first-page":"707865","DOI":"10.3389\/fitd.2021.707865","volume":"2","author":"N Salcedo","year":"2021","unstructured":"Salcedo N, Harmon A, Herrera BB. Pooling of samples for SARS-CoV-2 detection using a rapid antigen test. Front Trop Dis. 2021;2:707865.","journal-title":"Front Trop Dis"},{"issue":"3","key":"2720_CR44","doi-asserted-by":"publisher","first-page":"e0010311","DOI":"10.1371\/journal.pntd.0010311","volume":"16","author":"N Salcedo","year":"2022","unstructured":"Salcedo N, Reddy A, Gomez AR, Bosch I, Herrera BB. Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development. PLoS Negl Trop Dis. 2022;16(3):e0010311.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"2720_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1128\/jcm.23.4.667-671.1986","volume":"23","author":"CH Calisher","year":"1986","unstructured":"Calisher CH, Pretzman CI, Muth DJ, Parsons MA, Peterson ED. Serodiagnosis of La Crosse virus infections in humans by detection of Immunoglobulin M class antibodies. J Clin Microbiol. 1986;23(4):667\u201371.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2720_CR46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"TC Pierson","year":"2020","unstructured":"Pierson TC, Diamond MS. The continued threat of emerging flaviviruses. Nat Microbiol. 2020;5(6):796\u2013812.","journal-title":"Nat Microbiol"},{"key":"2720_CR47","doi-asserted-by":"crossref","unstructured":"Alatrash R, Herrera BB. Immunodominant structural proteins Gc and N drive T cell-mediated protection against La Crosse virus. BioRxiv. 2025:2025.02. 25.640063.","DOI":"10.1101\/2025.02.25.640063"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02720-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T20:03:41Z","timestamp":1744229021000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02720-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02720-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.21.634131","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BBH is a co-founder of Mir Biosciences, Inc., a biotechnology company focused on T cell-based diagnostics and vaccines for infectious diseases, cancer, and autoimmunity.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}